We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTED.L Regulatory News (TED)

  • There is currently no data for TED

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

26 Oct 2020 10:50

RNS Number : 1940D
Ted Baker PLC
26 October 2020
 

 

 

 

26 October 2020

Ted Baker Plc

(the "Company")

 

Notification of Transactions of Persons Discharging Managerial Responsibilities

 

The Company has been notified of the following transaction by the following Person Discharging Managerial Responsibilities ("PDMR").

The attached notification, made in accordance with the requirements of the EU Market Abuse Regulation, gives further detail.

 

Enquiries:

Ted Baker Plc

Peter Hearsey-Zoubie, Company Secretary

Tulchan Communications

Tel: +44 (0) 20 7353 4200

Jonathan Sibun/Jessica Reid/Will Palfreyman

 

 

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PDMRS AND PERSONS CLOSELY ASSOCIATED WITH THEM

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Helen Costello

2

Reason for the notification

a)

Position/status

 

Group Commercial and Business Development Director

b)

Initial notification/Amendment

 

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Ted Baker PLC

 

b)

LEI

549300HN14450OU4IL77

 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary Shares

 

 

GB0001048619

b)

Nature of the transaction

 

 

Award of nil-cost options pursuant to the Ted Baker Incentive Plan 2020.

c)

Price(s) and volume(s)

 

 

 

 

Price(s)

Volume(s)

1

NIL

193,808

d)

Aggregated information

- Aggregated volume

- Price

 

NA

e)

Date of the transaction

 

2020-26-10

f)

Place of the transaction

London Stock Exchange, Main Market (XLON)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHEAEEKALXEFFA
Date   Source Headline
15th Aug 20051:17 pmRNSRule 8.3- Tepnel Life Science
11th Aug 200512:02 pmRNSRule 8.3- Tepnel Life Science
10th Aug 20053:00 pmRNSResult of AGM
10th Aug 20057:01 amRNSTepnel Receives FDA Approval
1st Aug 200512:00 pmRNSBlocklisting Interim Review
1st Aug 200512:00 pmRNSBlocklisting Interim Review
26th Jul 20052:56 pmRNSRule 8.3- (Tepnel Life Sci)
15th Jul 20057:00 amRNSHolding(s) in Company
14th Jul 20054:45 pmRNSRule 2.10 Announcement
14th Jul 20057:00 amRNSTrading Statement
11th Jul 200512:31 pmRNSHolding(s) in Company
16th Jun 200512:21 pmRNSEGM Statement
16th Jun 200512:20 pmRNSAGM Statement
31st May 20051:43 pmRNSHolding(s) in Company
11th May 20053:30 pmRNSDirector Shareholding
14th Apr 200510:51 amRNSHolding(s) in Company
4th Apr 20054:06 pmRNSDirector Shareholding
31st Mar 20056:00 amPRNPreliminary Results 2004
24th Mar 20053:45 pmRNSDirector Shareholding
23rd Mar 20054:00 pmPRNCOMPANY ANNOUNCES STRATEGIC FOCUS
22nd Mar 200511:00 amPRNTepnel Life Sciences preliminary results reporting date
18th Mar 200511:13 amRNSTepnel launches new assay
17th Mar 20057:03 amRNSFinal Results
1st Mar 20057:00 amPRNCompany Strategy Briefing, March 22nd 2005
25th Feb 200512:29 pmRNSNotice of Results
2nd Feb 20057:00 amPRNTepnel signs R&D agreement with Boehringer Ingelheim
28th Jan 20052:45 pmRNSBlocklisting Interim Review
28th Jan 20052:31 pmRNSBlocklisting Interim Review
21st Jan 200512:20 pmRNSDirector Shareholding
19th Jan 20057:00 amRNSTrading Statement
7th Jan 200510:16 amRNSNotice of Trading Statement
6th Jan 20053:08 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.